Syneos Health Inc. (SYNH) shares are trading at lower $55.26 and the avg recommendation for the stock is Moderate Buy. while the current analyst price target stands at $73.38.
To add more color to this target, the company’s high over the last year is $74.25 and the low is $30.02. Over the last 52 weeks, SYNH is up 1.17% while the S&P 500 is up 12.59%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
In the last quarter, SYNH reported a profit of $207.51 million. Syneos Health Inc. also saw revenues increase to $1.01 billion. In addition, SYNH has free cash flow of $125.09 million as of 06-2020. The company’s EBITDA came in at $90.99 million which compares well with its peers.
FREE CONFIDENTIAL REPORT
3 Stocks Set To Soar By January 1st, 2021
You have Successfully Subscribed!
SYNH booked profit margins of 4.10%, its Return on Equity (ROE) is 6.30%, and its Return on Assets is 2.50%. All told, it is clear that, SYNH needs to be on your watchlist.
Find out when SYNH reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. SYNH has a short ratio of 8.79 and outstanding shares of 104.20M.
SYNH has seen increased volume after this news and investors are putting their support behind the value proposition. Traders will also note the company’s earnings per share came in at 1.78. Syneos Health Inc. SYNH also noted assets of $7.41 billion at the end of the last quarter. Investors should also keep an eye on sector updates as SYNH has historically followed its peers on positive news.
All told, Syneos Health Inc. SYNH has strung together solid data and demonstrated underlying fundamentals. At its current valuation, SYNH represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
Syneos Health Inc. SYNH is now commanding a market cap of 5.80B and a float of 61.30M. SYNH is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of SYNH stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in SYNH, either long or short, and we have not been compensated for this article.